Vancouver Coastal Health Research Institute (VCHRI) is proud to support future research leaders with the Top Graduating Doctoral Student Awards and the Rising Star Awards. These awards recognize the outstanding efforts of VCHRI trainees whose pursuit of research has made them exceptional role models and significant contributors to the Vancouver Coastal Health and University of British Columbia research community.
The 2025 Top Graduating Doctoral Student Award recipients are:
A pioneering study led by Vancouver Coastal Health Research Institute (VCHRI) researcher Dr. Calvin Kuo and Dr. Mahsa Khalili has demonstrated that consumer wearable technology may hold the key to transforming how out-of-hospital cardiac arrests (OHCAs) are detected, potentially saving countless lives.
Learning Health Systems is an increasing priority at Vancouver Coastal Health (VCH) and Vancouver Coastal Health Research Institute (VCHRI) that champions continuous learning through knowledge, practice and data collection to improve patient outcomes and experiences. Driven by the VCH value “we are always learning,” the Centre for Clinical Epidemiology and Evaluation (C2E2) at VCHRI is working to expand the reach and adoption of Learning Health Systems at VCH.
Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: A Multicentre Pilot Randomized Trial
Taking innovative research from concept to application is critical for improving health care systems and well-being of patients. Vancouver Coastal Health Research Institute (VCHRI) is proud to support investigators and their groundbreaking health research with the Innovation and Translational Research Awards. This year’s recipients are putting new knowledge into practice, implementing research outcomes and turning discoveries into commercial opportunities.
The 2025 Innovation and Translational Research Award recipients are:
A Randomized, Open-label, Parallel-group, 18-month Phase 3 Study to Evaluate the Effect of Venglustat Compared with Usual Standard of Care on Left Ventricular Mass Index in Participants with Fabry Disease and Left Ventricular Hypertrophy (CARAT)
Research is crucial to improving health outcomes and unlocking the potential of new medication, treatments and medical devices. However, it has historically excluded certain groups, including Indigenous Peoples, leading to biased results that do not accurately reflect the experiences of all Canadians. Expanding research to be more inclusive ensures findings are more representative of the broader population, leading to more impactful outcomes.
